The FDA approved and granted emergency use authorization Thursday for updated COVID-19 vaccines for the upcoming fall and winter season.
The U.S. Food and Drug Administration approved and granted emergency use authorization Thursday for updated COVID-19 vaccines for the upcoming fall and winter season.
The FDA said the vaccines will target the KP.2 strain, which is an offshoot of the omicron variant.
